THE PRIORITY AREAS OF COLLABORATIVE RESEARCH
Presently Council encourages collaborative studies in the following identified areas:
A. Translating classical/clinical experience through evidence-based experimental research
Non-communicable health conditions:
- Lifestyle disorders including cardiovascular diseases, obesity, and diabetes mellitus
- Musculoskeletal disorders
- Gastro-intestinal (digestive) and hepatobiliary (liver) disorders
- Respiratory disorders
- Skin diseases and anti-ageing
- Gynaecological disorders
- Sexual disorders
- Endocrine disorders
- Cognitive disorders
- Neurological disorders
- Autoimmune diseases
- Health conditions due to radiation, environmental pollution, and climate change
Communicable conditions i.e Viral, bacterial, or fungal infections
B. Adjuvant therapies To counter side effects of conventional medicines like cancer chemotherapy, anti-tuberculosis drugs, anti-retroviral drugs, epileptic drugs, etc.
C. Scientific validation of fundamentals and basic principles of Unani Medicine
D. Safety and pharmacology of Unani drugs
E. Pharmacokinetics and Pharmacodynamics of Unani drugs
F. Exploring the mechanism of action and physicochemical nature of drugs
G. Molecular and genetic correlation studies to understand temperament of patients, disease, diet, and drugs
H. Redesigning various dosage forms as per need and requirement
I. Developing organ-specific immunomodulators
J. Co-opting nanotechnology for Unani formulations
K. Co-opting Artificial Intelligence and Machine Learning for various diagnostic and treatment modalities and procedures